KCS Wealth Advisory’s Merck MRK Stock Holding History

KCS Wealth Advisory’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.3M	Sell	12,644 -1,330	-10%	-$143K	0.56%	51
2023 Q2	$1.61M	Buy	13,974 +314	+2%	+$35.7K	0.56%	51
2023 Q1	$1.45M	Sell	13,660 -203	-1%	-$21.9K	0.55%	50
2022 Q4	$1.54M	Buy	13,863 +21	+0.2%	+$2.15K	0.64%	52
2022 Q3	$1.19M	Sell	13,842 -1,431	-9%	-$128K	0.55%	60
2022 Q2	$1.39M	Buy	15,273 +290	+2%	+$25.7K	0.62%	61
2022 Q1	$1.23M	Buy	14,983 +788	+6%	+$62.1K	0.57%	63
2021 Q4	$1.09M	Sell	14,195 -105	-0.7%	-$8.36K	0.44%	75
2021 Q3	$1.07M	Buy	14,300 +777	+6%	+$59.1K	0.51%	68
2021 Q2	$1.05M	Buy	13,523 +167	+1%	+$12.4K	0.5%	73
2021 Q1	$982K	Buy	13,356 +868	+7%	+$64K	0.51%	75
2020 Q4	$975K	Buy	12,488 +140	+1%	+$10.7K	0.64%	60
2020 Q3	$977K	Sell	12,348 -520	-4%	-$40.7K	0.78%	49
2020 Q2	$950K	Buy	12,868 +64	+0.5%	+$4.82K	0.79%	49
2020 Q1	$940K	Buy	12,804 +242	+2%	+$19K	0.96%	35
2019 Q4	$1.09M	Sell	12,562 -161	-1%	-$13.2K	0.82%	54
2019 Q3	$1.02M	Sell	12,723 -256	-2%	-$20.5K	0.71%	50
2019 Q2	$1.04M	Buy	12,979 +307	+2%	+$23.5K	0.82%	42
2019 Q1	$1.01M	Buy	12,672 +1,904	+18%	+$142K	0.88%	38
2018 Q4	$785K	Buy	10,768 +106	+1%	+$7.48K	0.83%	44
2018 Q3	$722K	Buy	10,662 +1,211	+13%	+$77.2K	0.67%	61
2018 Q2	$547K	Sell	9,451 -130	-1%	-$7.33K	0.51%	88
2018 Q1	$498K	Buy	9,581 +1,641	+21%	+$88.6K	0.45%	90
2017 Q4	$426K	Buy	+7,940	New	+$440K	0.41%	96

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

KCS Wealth Advisory's MRK Position: Q3 2023 in Review

KCS Wealth Advisory reduced its Merck (MRK) stake by 9.5% in Q3 2023, selling an estimated $143K and leaving 12,644 shares worth $1.3M. The position accounts for 0.56% of the portfolio, ranked #51.

KCS Wealth Advisory first reported a position in MRK in Q4 2017 and has held it in 24 quarters since. The position peaked at $1.61M in Q2 2023. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

KCS Wealth Advisory held 12,644 shares of Merck worth $1.3M as of Q3 2023.
KCS Wealth Advisory sold 1,330 Merck shares in Q3 2023, an estimated $143K.
Merck made up 0.56% of KCS Wealth Advisory's portfolio in Q3 2023, its #51 holding.
KCS Wealth Advisory first reported a position in Merck in Q4 2017 and has held it in 24 quarters since.
KCS Wealth Advisory's Merck position peaked at $1.61M in Q2 2023.
3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on KCS Wealth Advisory's 13F filing for Q3 2023, filed 3 Nov 2023.